Scopus
YÖKSİS Eşleşti
Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
Genel Tip Dergisi · Nisan 2024
YÖKSİS Kayıtları
Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
Genel Tıp Dergisi · 2024 DOAJ: Directory of Open Access Journals
DOÇENT HALİL ÖZER →
Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
Genel Tıp Dergisi · 2024 DOAJ: Directory of Open Access Journals
PROFESÖR MEHMET KAYNAR →
Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
Genel Tıp Dergisi · 2024 DOAJ: Directory of Open Access Journals
PROFESÖR MUSTAFA KOPLAY →
Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
Genel Tıp Dergisi · 2024 TR DİZİN
DOÇENT ALİ FURKAN BATUR →
Makale Bilgileri
DergiGenel Tip Dergisi
Yayın TarihiNisan 2024
Cilt / Sayfa34 · 223-229
Scopus ID2-s2.0-105009438138
Özet
Objective: To compare the diagnostic performance for the detection of clinically significant prostate cancers and interobserver agreement between PI-RADS v2 and v2.1 Material and Method: The mpMRI images of 258 patients and 394 nodüles included in this retrospective study were obtained on 3T MR and evaluated by two radiologists according to PI-RADS v2 and v2.1. Sensitivity and specificity between v2 and v2.1 were compared. Detection rates for clinically significant prostate cancers were evaluated. Interobserver agreement was evaluated using κ statistics. Results: PI-RADS v2.1 and v2 had higher sensitivity and lower specificity (100%, 52.38%) in the peripheral zone, and showed higher sensitivity and specificity (92.86%, 98.79%) in the transition zone for category ≥4 lesions to estimate csPCa, but no remarkable difference was found between the two versions. Interobserver agreement was statistically significant and very weak in the transition zone (κ=0.383, κ=0.279, respectively), very strong in the peripheral zone (κ=0.869) according to both classifications and they were similar. Conclusion: The diagnostic performance of PI-RADS v2 and v2.1 were found similar in the determination of clinically significant cancers and all cancers in both zones. The clinically significant cancer detection rate in category 2+1 lesions in the transition zone was higher than in category 2 lesions but it was not statistically significant. Interobserver agreement was low in the transition zone and very strong in the peripheral zone in both versions.
Yazarlar (7)
1
Ahmet Baytok
ORCID: 0000-0003-1615-5771
2
M. Koplay
ORCID: 0000-0001-7513-4968
3
Halil Özer
ORCID: 0000-0003-1141-1094
4
Ömer Faruk Topaloglu
5
Mehmet Kaynar
ORCID: 0000-0002-6957-9060
6
Serdar Goktas
ORCID: 0000-0001-6538-7187
7
Ali Furkan Batur
ORCID: 0000-0001-7945-7326
Anahtar Kelimeler
clinically significant prostate cancer
interobserver agreement
PI-RADS V2.1
Kurumlar
Karapinar State Hospital
Konya Turkey
Selçuk Tip Fakültesi
Konya Turkey